Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
CYHB2400600	恩曲他滨丙酚替诺福韦片（Ⅱ）	emtricitabine;tenofovir alafenamide	Tablet	Chemical Drugs(4)	Supplementary Application	2024-05-08	Shanghai DESANO Biopharmaceutical Co Ltd	view
CYHB2400441	恩曲他滨丙酚替诺福韦片（Ⅱ）	emtricitabine;tenofovir alafenamide	Tablet	Chemical Drugs(4)	Supplementary Application	2024-03-30	Chengdu Brilliant Pharmaceutical Co Ltd	view
CYHS2300939	恩曲他滨丙酚替诺福韦片（Ⅱ）	emtricitabine;tenofovir alafenamide	Tablet	Chemical Drugs(4)	Generic Drug	2023-03-31	North China Pharmaceutical CompanyLtd;North China Pharmaceutical HUAKUN Hebei BIOTECHNOLOGY Co Ltd	view